Skin Models

2
Feb

APPLICATION NOTE – NativeSkin® & UV testing

Explore how NativeSkin® supports ethical, human-relevant, and translational research in UV testing, phototoxicity assessment, and photobiology.

22
Oct

APPLICATION NOTE – Toxicity services for pharma, biotech & medical devices developers

Download this application note and discover 3 case studies. Refine formulations or assess local tolerance in human skin before clinical trials.

25
Sep

POSTER – ADCC Argenx poster

Prove ADCC Activityin real human skinFor therapies targeting mast cells, demonstrating antibody-dependent cell-mediated cytotoxicity (ADCC) in complex human tissue is essential.Traditional in vitro assays provide limited context, leaving critical aspects of biological impact unclear. HypoSkin® offers a solution Our ex vivo human skin model lets you assess mast cell depletion in situ, offering a powerful, human-relevant platform to confirm the
Read more
10
Sep

WHITE PAPER – HypoSkin® & immunogenicity testing

Explore how HypoSkin®—a standardized, injectable, and immunocompetent human skin model—provides a translational, animal-free solution for assessing the immunogenicity of therapeutic compounds. From structural stability to real-time immune response profiling, this white paper delivers data-backed insights designed for pharma and biotech teams advancing injectable drug development.

20
May

APPLICATION NOTE – NativeSkin® & Pharma

Explore how NativeSkin® supports ethical, human-relevant, and translational research for pharma.

2
Apr

Advancing medical device development with ex vivo human skin

Advancing medical device development with ex vivo human skinMedical devices are evolving rapidly, becoming more sophisticated and diverse in their applications. From injectable drug delivery systems to wound dressings, wearable sensors, and microneedles, these innovations must undergo rigorous testing to ensure safety, functionality, and biocompatibility. However, as medical devices become more complex, so do the challenges associated with their preclinical
Read more